| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/24/2004 | CN1484530A Use of enzymes obtainde from ciliates as medicaments for promoting digestion |
| 03/24/2004 | CN1484528A Pharmaceutical composition comprising wikstromol and/or mataires inal, its use as hepatoprotectant and process for their isolation from cedurs deodara |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1484524A 5-HT IA veceptor subtype agonist |
| 03/24/2004 | CN1483801A Health care wine containing dihydro-myricetin and myricetin composition |
| 03/24/2004 | CN1483471A Lucid ganoderma compound liguon |
| 03/24/2004 | CN1483450A Nutritious health care food and preparation prlcess thereof |
| 03/24/2004 | CN1483444A Formula of rehmannia root effervescence preparation and process for preparing same |
| 03/24/2004 | CN1483442A Traditional Chinese medicine for treating virus hepatitis and preparation process thereof |
| 03/24/2004 | CN1483441A Formula for Weitaihe (stomach medicine) and preparation process thereof |
| 03/24/2004 | CN1483439A Preparation for treating chronic exhaustion syndrome and process for preparing same |
| 03/24/2004 | CN1483432A Clathrate compound of daemonorops draco |
| 03/24/2004 | CN1483431A Pill for treating hepatitis B |
| 03/24/2004 | CN1483424A Lithagogue decoction |
| 03/24/2004 | CN1483416A Anti-inplammatory lozenge for treating tonsillitis, stomatitis and gingivitis |
| 03/24/2004 | CN1483414A Animal cephalin capsule |
| 03/24/2004 | CN1483413A Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products |
| 03/24/2004 | CN1483411A Licorzinc solution composition, preparation process thereof and licorzinc preparation |
| 03/24/2004 | CN1483410A Medicinal complsition containing vitamin B 1, preparation process and use thereof |
| 03/24/2004 | CN1483406A Maltilate emulsion and preparation proless thereof |
| 03/24/2004 | CN1483405A Aqueous injection of curcuma oil extract and preparation process and use |
| 03/24/2004 | CN1483327A Health care food containing dihydromyricetin and myricetin composition |
| 03/24/2004 | CN1142933C Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical composition thereof |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142792C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 03/24/2004 | CN1142785C Antifatigue capsule |
| 03/24/2004 | CN1142781C Use of 9-deoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'- interphenylene)-13,14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 03/23/2004 | US6710179 Compounds with analgesic effect |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709671 Water soluble film for oral administration with instant wettability |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | US6709656 Polyclonal and/or monoclonal immunoglobulin immunization |
| 03/23/2004 | US6709651 Administering peptidase; substance p antagonist; central nervous system disorders |
| 03/23/2004 | CA2168432C Piperazine compounds used in therapy |
| 03/23/2004 | CA2101575C New cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022727A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022585A1 Hbv precore protein capable of forming particles |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022543A1 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 03/18/2004 | WO2004022535A1 Acrylamide derivatives |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004014289A3 Use of beta-cyclodextrin (cas rn: 7585-39-9) in the preparation of medicaments for the treatment of human and animal diseases caused by cryptosporidium parasites |
| 03/18/2004 | WO2004009583A3 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 03/18/2004 | WO2004002983A3 Therapeutic piperazine derivatives useful for treating pain |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003099289A3 Compositions and their uses for alleviating pain |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003094830A3 Novel azacyclic ethynyl derivatives |
| 03/18/2004 | WO2003087094A3 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003039434A3 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 03/18/2004 | WO2003026670A3 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags) |
| 03/18/2004 | WO2003025155A8 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 03/18/2004 | WO2003018535A3 Novel aminobenzoephenones |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | US20040054313 Mixture with flow control agents; antiulcer agents |
| 03/18/2004 | US20040054187 Therapeutic ureas |
| 03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054001 For preparing a pharmaceutical composition for treating diseases that may be influenced by NF-kappaB, particularly psoriasis |
| 03/18/2004 | US20040053982 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 03/18/2004 | US20040053976 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 03/18/2004 | US20040053957 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053947 Pyrrolo[2,3-D]pyrimidine compounds |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053937 Pyrimidine compounds |
| 03/18/2004 | US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
| 03/18/2004 | US20040053921 Compounds useful as reversible inhibitors of cysteine proteases |
| 03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/18/2004 | US20040053896 Pharmaceutically active compound |
| 03/18/2004 | US20040053869 Stem cell differentiation |
| 03/18/2004 | US20040053853 Topiramate salts and compositions comprising and methods of making and using the same |
| 03/18/2004 | US20040053852 Preventing desensitization of receptors |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |